Maintenance Therapy in Mantle Cell Lymphoma
This video reviews different strategies for maintenance therapy in mantle cell lymphoma, as well as highlighting upcoming research in this setting.
In this video, Brad S. Kahl, MD, of the Washington University School of Medicine in St. Louis, Missouri, reviews the goals of maintenance therapy for the treatment of patients with mantle cell lymphoma, as well as highlighting different maintenance strategies and upcoming research in this setting.
Kahl spoke on this topic during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held last month in Chicago.
Brexu-cel Yields Robust Responses in Pretreated R/R Mantle Cell Lymphoma
December 6th 2023Median overall survival appears to be higher in patients who were previously treated with relapsed/refractory mantle cell lymphoma and who receive brexucabtagene autoleucel compared with standard therapy.
Oncology Peer Review On-The-Go: Minority Treatment Disparities and Clinical Trial Enrollment
July 6th 2020The first episode of CancerNetwork's podcast Oncology Peer Review On-The-Go explores disparities in cancer care treatment among minorities and the significance of a representative sample in clinical trials.